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TransciptionWe recently characterized the interaction between the intraviral domains of envelope glycoproteins (Gn and
Gc) and ribonucleoprotein (RNP) of Puumala and Tula hantaviruses (genus Hantavirus, family Bunyaviridae).
Herein we report a direct interaction between spike-forming glycoprotein and nucleic acid. We show that the
envelope glycoprotein Gn of hantaviruses binds genomic RNA through its cytoplasmic tail (CT). The nucleic
acid binding of Gn-CT is unspeciﬁc, as demonstrated by interactions with unrelated RNA and with single-
stranded DNA. Peptide scan and protein deletions of Gn-CT mapped the nucleic acid binding to regions that
overlap with the previously characterized N protein binding sites and demonstrated the carboxyl-terminal
part of Gn-CT to be the most potent nucleic acid-binding site. We conclude that recognition of the RNP
complex by the Gn-CT could be mediated by interactions with both genomic RNA and the N protein. This
would provide the required selectivity for the genome packaging of hantaviruses.aartman Institute P.O. Box 21
nd. Fax: +358 9 191 26491.
in).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Rodent- and insectivore-borne hantaviruses (genus Hantavirus) are
enveloped viruses that together with four other genera (Orthobunya-,
Nairo-, Phlebo- and Tospovirus) constitute the family Bunyaviridae
(Elliott et al., 2000; Nichol et al., 2005). The asymptomatic carrier
rodents and insectivores spread hantaviruses in their excreta, which is
considered the main route for transmission to humans (Jonsson et al.,
2010; Kariwa et al., 2007; Vaheri et al., 2011).When transmitted toman
hantaviruses cause two severe diseases: hemorrhagic fever with renal
syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS).
Old World hantaviruses include causative agents of HFRS, whereas the
hantaviruses found in the NewWorld have been associated with HCPS
(Mir, 2010; C. Schmaljohn and Hjelle, 1997). Additionally hantaviruses
cause nephropathia epidemica, a mild form of HFRS, that occurs mainly
in Northern Europe (Vaheri et al., 2008; Vapalahti et al., 2003).
The single-stranded, negative-sense RNA genome of hantaviruses
is segmented into small (S), middle (M) and large (L) segments
encoding nucleocapsid (N) protein, glycoproteins (Gn and Gc) and the
RNA-dependent RNA polymerase (L protein), respectively (Plyusnin
et al., 1996). The RNA genome is encapsidated via oligomerization of N
protein to form RNP complexes (Alfadhli et al., 2001; Alfadhli et al.,
2002; Alminaite et al., 2006; Alminaite et al., 2008; Kaukinen et al.,2005; Wang et al., 2008). The RNPs interact with the spike complex,
formed of four units of both Gn and Gc glycoproteins (Battisti et al.,
2010; Hepojoki et al., 2010a; Huiskonen et al., 2010), by binding to the
cytoplasmic tails (CTs) of both Gn and Gc (Hepojoki et al., 2010b;
Wang et al., 2010).
For enveloped viruses it is common that the contacts between RNP
and envelope proteins aremediated by amatrix protein (Timmins et al.,
2004). However, members of the family Bunyaviridae do not contain a
separate matrix protein and therefore interactions between the spike
complex andRNPs are assumed to initiate assembly of the virions. Of the
two hantavirus glycoprotein CTs, Gn-CT is considerably larger and
capable of forming domain structures (~110 amino acids) while Gc-CT
represents an intraviral insertion of a transmembrane anchor (~10
amino acids). The Gn-CT harbors a tandem zinc ﬁnger (ZF) fold, the
structure of whichwas resolved by nuclear-magnetic resonance (NMR)
(Estrada et al., 2009). Gn-CT carries also a conserved endocytosis signal
YxxL, functionally characterized in many cell surface proteins (Owen
and Evans, 1998), but its role in hantaviruses remains elusive. Thismotif
resembles a class of late domain (L-domain) motifs (Bieniasz, 2006;
Groseth et al., 2010), that are commonly utilized by matrix proteins to
drive the budding process of viruses. Taken together, the Gn-CT is
assumed to operate as a surrogate matrix protein of hantaviruses.
We previously reported that both Gn-CT and Gc-CT are able to bind
isolated RNP, and interact with puriﬁed recombinant N protein
(Hepojoki et al., 2010b; Wang et al., 2010). We showed that the Gn-
CT is fundamental to the RNP-spike interaction in the case of native
proteins. Additionallywe found that there are at least three binding sites
in the Gn-CT towards N protein which are located on either side
Fig. 1. Cross-linking of exogenous genomic
32
P-RNA to PUUV proteins. Expression of in
vitro transcribed
32
P-labeled PUUV S segment RNA (
32
P-S-RNA) and an unrelated RNA
(
32
P-unRNA) of similar size (2 kB) are shown in urea-PAGE (A). The S-RNA (500 CPM)
was incubated with puriﬁed MNase-treated PUUV lysate, UV cross-linked, treated with
RNase A and the proteins were separated in 6% SDS-PAGE (B). As indicated, the PUUV
proteins were detected by immunoblotting using Gn- or Gc-speciﬁc PAb and N-speciﬁc
MAb 5E1, a combination of appropriate IRDye-conjugated secondary antibodies and
Odyssey infrared imaging. Protein-bound nucleotides were detected by autoradiogra-
phy. M indicates the marker lane.
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Recent studies suggest that Gn-CTs of Rift Valley Fever virus (RVFV,
genus Phlebovirus) and Crimean-Congo hemorrhagic fever virus
(CCHFV, genus Nairovirus) are able to interact with genomic RNA
(Estrada and De Guzman, 2011; Piper et al., 2011). For CCHFV this
interaction was shown to involve a ZF domain of Gn-CT that closely
resembles the one found in hantaviruses. However, in the same study
the ZF domain of hantaviruses could not bind RNA when expressed
without the ﬂanking regions. In this report we aimed to investigate the
ability of the full Gn-CT of hantaviruses to interact with genomic RNA.
We show an interaction between PUUVGn (but not Gc) and exogenous
32
P-labeled genomic RNA by cross-linking and co-immunoprecipitation
experiments. The nucleic acid binding site is pin-pointed to Gn-CT using
GST-fused recombinant proteins and synthetic peptides. The results
indicate that the binding ability of Gn-CT towards nucleic acids is rather
unspeciﬁc since in addition to genomic RNA, also unrelated RNA aswell
as single-stranded DNA was able to interact with Gn-CTs of PUUV and
TULV. The nucleic acid binding activity of hantavirus Gn-CT resided
predominantly at the C-terminal part of the protein. In conclusion weFig. 2. Cross-linking of exogenous
32
P-RNA to TULV proteins. TULV RNA-binding proteins wer
and autoradiography as described in Fig. 1B (A). Two different autoradiography exposures (l
S-RNA vs. unRNA (500 vs. 2500 CPM; speciﬁc activities of the probes were similar). Redu
preparations were treated and immunoblotted as described in Fig. 1B but without exogenohypothesize the RNA–Gn-CT interaction to be linked to the assembly
process of hantaviruses.
Results
Cross-linking of RNA to PUUV and TULV Gn
Weassessed biochemically,whether one or both of the glycoproteins
of PUUV would directly bind genomic RNA. Puriﬁed, lysed and
micrococcal nuclease (MNase)-treated virus preparation and in vitro
transcribed and radiolabeled genomic PUUV S segmentwere allowed to
form RNA–protein complexes prior to UV cross-linking. Samples were
subsequently treated with RNase A in order to facilitate separation of
proteins according to their molecular size in SDS-PAGE. Proteins were
detected by Western blotting using N, Gn and Gc antibodies. The RNA
binding to viral proteinswas studied in parallel by separating identically
treated sample in SDS-PAGE and using autoradiography for detection.
Firstly, the successful transcriptions of the S segment (~2 kilobases {kB})
together with an unrelated marker RNA (unRNA of 2 kB) were veriﬁed
on a TBE-Urea gel (Fig. 1A). From Fig. 1B it is evident that the bands
migrating above 250 kDa and at 50 kDa remained radiolabeled after
RNase A-treatment, indicating cross-linking of RNA to proteins of the
indicated sizes. Interestingly, the most intense radioactivity (above
250 kDa) overlapped with the band recognized by anti-Gn immunoblot
which suggested that the genomic RNA interacts with Gn. The band
detected by autoradiography at 50 kDa overlapped with the band
recognized by N protein immunoblot. This was expected since the RNA-
binding properties of N protein are well-characterized (Gott et al., 1993;
Mir and Panganiban, 2004; Severson et al., 1999).
Next we performed similar experiments as before using TULV as
the source of viral proteins (Fig. 2A). In addition to the genomic S
segment RNA of PUUV, we used an excessive amount of radiolabeled
unrelated RNA (unRNA) as a non-genomic RNA substrate to analyze
the RNA-binding speciﬁcity of viral proteins. Similarly to what was
observed using PUUV, the radioactivity after RNase A-treatment was
retained in the bands that by migration represent Gn and N proteins.
The same pattern of RNA-bound proteins was observed with
exogenous hantavirus S segment and the unRNA. The capacity of
both N and Gn protein to bind both viral and unRNA suggests that the
RNA-binding activity of these proteins did not absolutely require a
speciﬁc sequence or structure of the RNA substrate. However, our
experimental set-upwas not optimized to study the binding afﬁnity of
proteins to different RNA sequences since the amounts of added RNAs
differed and thus we cannot rule out the possibility that viral proteinse detected byWestern blotting (using Gn- or Gc-speciﬁc PAb and N-speciﬁc MAb 3C11)
ong and short) emphasize the difference in the concentrations of the applied exogenous
ced mobility of Gn in SDS-PAGE due to UV-induced cross-linking is shown (B). TULV
us RNA.
Fig. 3. Immunoprecipitation of exogenous
32
P-RNA by hantavirus proteins. Lysates of
metabolically
35
S-Cys and
35
S-Met labeled and puriﬁed PUUV or TULV were subjected to
immunoprecipitation by Gn- or Gc-speciﬁc PAbs, proteins separated in 10% SDS-PAGE
and detected by autoradiography (A). Negative serum was used as a control (−). Viral
proteins, according to their typical migration in SDS-PAGE, are indicated. Co-
immunoprecipitation of 500 CPM
32
P-S-RNA (B) or 2500 CPM
32
P-unRNA (C) with
puriﬁed, lysed and MNase-treated PUUV or TULV proteins, respectively, are shown. The
radioactivity retained on protein G Sepharose-beads after immunoprecipitation was
measured by scintillation counting and the fold of change as compared to negative
serum is indicated. The MAbs 5A2, 4G2 and 5E1 are speciﬁc for PUUV Gn, PUUV Gc and
PUUV N, respectively. The MAb indicated HA is speciﬁc for hemagglutinin-tag and used
as a negative control.
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while N and Gc proteins migrated mainly as monomers, the mobility
of PUUV and TULV Gnwere drastically reduced after RNA-binding and
UV-induced cross-linking (Figs. 1B and 2A). To assess whether this
phenomenon is due to cross-linking alone we treated TULV as before
but without the addition of exogenous RNA (Fig. 2B). The mobility of
Gn was clearly reduced by UV cross-linking thereby showing that the
exogenously applied RNA is probably not responsible for the reduced
mobility of Gn in SDS-PAGE.
Co-immunoprecipitation of RNA with Gn
Next wewanted to conﬁrm the ability of Gn to bind RNA and chose
to use co-immunoprecipitation with the well-described PUUV-
speciﬁc monoclonal antibodies (MAbs) 5A2 (Gn-speciﬁc), 4G2 (Gc-
speciﬁc) and 5E1 (N-speciﬁc) in parallel with rabbit polyclonal
antibodies (PAbs) directed to PUUV Gn, Gc or N. Since these PAbs are
known to cross-react with TULV proteins in Western blot, we ﬁrstly
wanted to verify their ability also to immunoprecipitate the envelope
proteins of TULV. For this purpose we used metabolically radiolabeled
lysates of both PUUV and TULV as the source of viral proteins in
immunoprecipitation with Gn- and Gc-speciﬁc PAbs. Immunopreci-
pitated proteins were separated in SDS-PAGE and detected by
autoradiography according to their typical migration pattern
(Fig. 3A). The results demonstrated that the Gn- and Gc-speciﬁc
PAbs cross-react between PUUV and TULV and in both cases
precipitate, in addition to their respective target antigens, also a
complex formed of Gn and Gc. Unexpectedly the PUUV Gc PAb
seemed to precipitate TULV Gcmore efﬁciently than its native antigen.
This suggests differences in the accessibility between Gc of PUUV and
TULV towards this PAb. Both PAbs favor their target antigens over the
Gn–Gc complex which is in contrast to the PUUV Gn- and Gc-speciﬁc
MAbs 5A2 and 4G2 that both precipitate close to equimolar amounts
of Gn and Gc (Hepojoki et al., 2010a; Hepojoki et al., 2010b; Strandin
et al., 2011).
The capability of structural proteins to bind RNA was analyzed by
incubating puriﬁed, lysed and micrococcal nuclease (MNase)-treated
virus preparations with radioactive PUUV S segment RNA in the
case of PUUV (Fig. 3B) and unrelated RNA in the case of TULV (Fig. 3C)
as was done in the cross-linking experiments (Figs. 1B and 2A).
The samples were immunoprecipitated with MAbs or PAbs speciﬁc to
N, Gn or Gc and retained radioactivity on protein G beads after
washing was measured by scintillation counting. The amount of
precipitated RNA is reported as a fold of increase compared to the
value obtained with negative PAb. The Gn-speciﬁc antibodies
precipitated the highest amount of RNA in the case of both PUUV
and TULV, and thus the RNA-binding activity of Gn was further
solidiﬁed. The substantially higher amount of RNA precipitated by
TULV Gn compared to PUUV Gn is at least partially explained by the
different amounts of applied RNA (approximately 5 times more of
unRNA than S segment RNA). The amount of viral proteins in
precipitates of PUUV and TULV was nearly the same (Fig. 3A)
suggesting that the maximum RNA-binding capacity of PUUV Gn
could be considerably higher than detected with the amount of
exogenous S segment RNA used in this experiment.
Surprisingly, the antibodies against N protein precipitated exog-
enous RNA–N protein complexes very weakly if at all. The likely
explanation to this is a nuclease-induced aggregation or modiﬁcation
of the N protein, thus rendering it unrecognizable by antibodies.
Another possibility could be inefﬁciency of nucleases to degrade the
endogenous N protein-bound genomic RNA. This would also explain
the fairly low amount of exogenous RNA cross-linked to N protein as
compared to Gn in the cross-linking experiments (Figs. 1B and 2A).
The fact that Gc-speciﬁc MAb 4G2 precipitated more RNA than Gc-
speciﬁc PAb is probably due to effective co-immunoprecipitation of
the Gn–Gc complex by this MAb, as mentioned earlier.The nucleic acid binding activity of PUUV and TULV Gn is retained in
their cytoplasmic tails
Based on our results using native viral proteins, the Gn of both
PUUV and TULV can bind RNA. In the native virion or in infected cells
the Gn protein can only encounter nucleic acids via its cytoplasmic tail
and therefore the RNA-binding activity should reside in this part of
the protein to be biologically relevant. The ability of Gn-CT of PUUV
and TULV to bind nucleic acids was studied with GST-fused Gn-CTs
Fig. 4. Pull-down of nucleic acids by GST-fused hantavirus Gn cytoplasmic tails. PUUV and TULV Gn cytoplasmic tails (CT) were expressed as GST-fusion proteins in parallel with plain
GST, separated in 6% SDS/Tricine-PAGE, blotted onto nitrocellulose and visualized by Ponceau S staining (A). M indicates a marker lane. Glutathione beads loaded with PUUV and
TULV Gn-CT were used to pull-down a similar amount of PUUV
32
P-S-RNA (400 CPM) or
32
P-unRNA (500 CPM) (B). The bead-retained radioactivity was measured by scintillation
counting. In comparison IRdye800-conjugated DNA, instead of RNA, was used in pull-down. The 42-mer single stranded DNA (sequence derived from PUUV S-segment 3′-end) was
bound to GST-Gn-CTs at 100 nM, eluted from glutathione beads by Laemmli sample buffer, cross-linked onto a nitrocellulose membrane and quantiﬁed by Odyssey infrared imaging.
Results of RNA and DNA pull-downs are reported as a fold increase as compared to plain GST.
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the recombinant proteins eluted from GSH-beads was analyzed by
Ponceau S staining (Fig. 4A). The RNA-binding of bead-bound Gn-CTs
of either PUUV S segment or unrelated RNA, which were applied in
similar radiolabeled amounts, was measured by scintillation counting.
In parallel, we also tested with single-stranded 42-mer DNA whether
the Gn-CTs would bind DNA. The sequence of this IRdye800-labeled
DNAwas derived from the 3′-end of the PUUV genomic S segment and
the binding of this DNA was detected by Odyssey infrared imaging.
We compared the amounts of Gn-CT bound nucleic acids to plain GST
and report the results as fold change (Fig. 4B). The results indicated
that the Gn-CTs of PUUV and TULV bind to both RNA and DNA. The
observed difference in nucleic acid binding between Gn-CT of TULV
and Gn-CT of PUUV is likely due to a higher level of expression of TULV
Gn-CT as compared to PUUV Gn-CT as demonstrated in Fig. 4A. It
seems that there is also more plain GST in the PUUV Gn-CT
preparation as compared to TULV Gn-CT. However, since plain GST
as negative control did not show signiﬁcant binding to nucleic acids,
this should not inﬂuence the obtained results. The fact that the
unrelated RNA bound both CTsmore efﬁciently than the genomic RNA
and the ability of Gn-CT to bind also relative short DNAs further
solidiﬁes the unspeciﬁc nature of the nucleic acid recognition of Gn-
CT. However, due to the different detection methods used, we could
not directly compare the binding strength of RNA vs. DNA.Peptide mapping of nucleic acid binding sites in PUUV Gn-CT
To deﬁne the regions in Gn-CT that bind nucleic acids, we
synthesized the Gn-CT of PUUV as overlapping 20-mer peptides in a
3 residue shift in CelluSpot™ format. The CelluSpot™ array was
probed with the IRdye800-conjugated DNA shown to interact with
the GST-tagged Gn-CT of PUUV (Fig. 4B). The mapping indicated that
the same peptides that were previously shown to interact with RNP
and N protein (Hepojoki et al., 2010b) were capable of binding also
nucleic acids (Fig. 5A). Next we wanted to study the nucleic acid
binding capacity of the three binding sites individually using
biotinylated soluble peptides GnN, GnM and GnC, which represent
the N-binding sites 1, 2 and 3 of PUUV Gn-CT as described earlier(Hepojoki et al., 2010b). Schematic presentation of the peptides with
respect to the primary sequence of PUUV Gn-CT is shown in Fig. 6. We
also used the synthetic peptide corresponding to Gc-CT, which in the
earlier study was also shown to bind N protein (Hepojoki et al.,
2010b). The peptides were pre-bound to avidin beads through biotin
and analyzed for RNA- or DNA-binding activity similarly as was done
for GST-fused proteins (Fig. 4). The GnC showed the strongest binding
of the analyzed peptides irrespective of the applied nucleic acids
(Fig. 5B). Also GnM showed signiﬁcant RNA-binding capacity but only
very little DNA-binding activity. The binding levels of GnN and Gc-CT
were above control (biotin-bound avidin beads) but clearly lower
than those of GnM or GnC. In addition, in the case of Gc-CT, this
observed interactionmight not have any biological relevance since we
did not detect any cross-linking of RNA to native Gc (Figs. 1 and 2).Mapping of the nucleic acid binding site in TULV Gn-CT
Finally we were interested in mapping the nucleic acid binding
sites of TULV Gn-CT and thus performed a similar CelluSpot™ assay as
with PUUV Gn-CT, shown in Fig. 5A. The strongest DNA-binding
peptides of TULV Gn-CT (Fig. 7A) located to the C-terminal part of the
protein and overlapped with the corresponding sequence of PUUV
GnC peptide. This result suggested that the main nucleic acid binding
site in Gn is conserved among hantaviruses and locates to the C-
terminal part of the Gn-CT which contains the putative late domain
motif YRTL and is adjacent to the membrane-spanning signal
sequence for Gc. To conﬁrm the signiﬁcance of this region to nucleic
acid binding we used a previously described (Wang et al., 2010)
truncated GST-fusion protein of TULV Gn-CT lacking the C-terminal
DNA-binding sequence (Figs. 6 and 7B). When comparing the RNA-
and DNA-binding activities of this mutant (Gn-CTdel13) to the full-
length Gn-CT of TULV in a similar GST pull-down as before, we
observed that the RNA-binding capacity of themutant was completely
abolished (Fig. 7C). However, the DNA-binding activity was seen only
to diminish due to the deletion of the C-terminal part, and thus we
conclude that while the whole Gn-CT containing the ZF domain might
be important in regulating nucleic acid binding it is the C-terminal
part that is mainly responsible for this activity.
Fig. 5. Mapping of the nucleic acid binding sites in the Gn-CT of PUUV. The Gn-CT
(amino acids 525–638) was synthesized in CelluSpot™ format as partially overlapping
20-residue peptides with a 3-residue shift. The CelluSpotTM slide was probed with the
IRdye800-conjugated 42-mer single-stranded DNA (A). The signal detected in Odyssey
infrared imaging for each individual peptide is shown on the left side next to the amino
acid sequence of the respective peptide. The indicated binding sites 1–3 were
determined for N protein using SPOT peptide assay as previously described (Hepojoki
et al., 2010b; Wang et al., 2010), and are colored grey. PUUV Gn-CT peptides were used
to pull-down nucleic acids (B). Monomeric avidin beads preloaded to saturation by the
biotinylated peptides GnN, GnM, GnC and Gc-CTwere used to pull-down RNA (
32
P-S-RNA
in 400 CPM and
32
P-unRNA in 500 CPM) or IRdye800-conjugated DNA (IRdye800-
conjugated 42mer 3′-end of hantavirus S-segment, 100 nM) and detections were done
by scintillation counting and Odyssey infrared imaging, respectively. Results are
indicated as a fold increase in respect to biotin-saturated avidin beads.
Fig. 6. Scheme of Gn-CT peptides and proteins used to map nucleic acid-binding sites in
PUUV and TULV. The full length cytoplasmic tails of PUUV and TULV Gn (111 amino
acids) and TULV Gn-CT with 13 residue C-terminal deletion (Gn-CTdel13) were
expressed as N-terminal GST-fusion proteins (Wang et al., 2010). Biotinylated peptides
(GnN, GnM and GnC) derived from PUUV Gn-CTwas synthesized as described previously
(Hepojoki et al., 2010b). The amino acid numbers in the image refer to the PUUV or
TULV glycoprotein precursors.
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In this report we show using several techniques that the Gn
protein of hantaviruses is able to bind nucleic acids and map this
interaction to its CT. Furthermore, by using peptide array we were
able to pin-point this interaction to the very C-terminus of Gn-CT. In
our previous study we demonstrated that the CTs of both Gn and Gc
interact with the native RNP consisting of N protein and N protein-
encapsidated genomic RNA (Hepojoki et al., 2010b; Wang et al.,
2010). We also showed recombinant N protein to be able to mediatebinding to Gn- and Gc-CT; however, we were unable to rule out the
involvement of nucleic acids in these interactions. The results in this
report show that the N protein encapsidated genomic RNA could be
directly involved in the interaction between glycoprotein CTs and
RNP. This is supported by the fact that the binding sites of nucleic
acids and N protein either overlap or are contiguous in the primary
sequence of Gn-CT. Thus amino acid residues of N protein and
nucleotides from genomic RNA would form the interaction surface in
RNP that mediates the binding to glycoprotein CTs. Our results
corroborate recent ﬁndings suggesting that Gn-CTs of other bunya-
viruses could bind genomic RNA. For RVFV of phleboviruses it was
demonstrated that genomic RNA is required for the efﬁcient release of
infectious VLPs and the authors hypothesized that this would occur
through direct recognition of viral RNA by Gn-CT (Piper et al., 2011).
Furthermore a ZF domain in Gn-CT of CCHFV (nairovirus), closely
resembling the one found in hantavirus Gn-CT (Estrada et al., 2009),
was found to bind viral RNA and again a role for this interaction in
virus assembly was suggested (Estrada and De Guzman, 2011).
Speciﬁc recognition of the RNP structure is a crucial step in the egress
of envelopedviruses. During infection the cellsmay contain various types
of nucleic acids encapsidated by the viral nucleoproteins; however,
mainly the genomic RNA is incorporated into virions and this requires
accentuated regulation of genome packaging. Several enveloped viruses
encode a matrix protein that bridges between the RNP and the viral
envelope. Hantaviruses do not possess an individual matrix protein and
based on recent evidence, instead, the relatively large Gn-CT substitutes
for this activity (Battisti et al., 2010; Hepojoki et al., 2010a; Huiskonen
et al., 2010; Wang et al., 2010). The matrix protein of both family
Bornaviridae (Neumann et al., 2009) and Orthomyxoviridae (Elster et al.,
1997; Wakeﬁeld and Brownlee, 1989; Ye et al., 1989) viruses have been
shown to bind, in addition to the viral core proteins, also the genomic
RNA. Thus our results suggest by analogy the Gn-CT of hantaviruses to be
equivalent of a matrix protein in the family Bunyaviridae. Prior to recent
reports for CCHFV and RVFV (Estrada and De Guzman, 2011; Piper et al.,
2011), interaction involving a viral envelopeprotein and its genomicRNA
has only been shown for the family Coronaviridae, where the envelope
protein M recognizes the viral RNA packaging signal and incorporates
itself in to the nascent virions independently of the core protein
(Narayanan et al., 2003). However, the M protein of coronaviruses
possesses only a tiny extracellular domain, thus differing from the spike-
forming glycoprotein Gn of hantaviruses.
The segmented, negative-sense RNA viruses are divided in three
families:Orthomyxoviridae, Bunyaviridae and Arenaviridae. In the case of
Fig. 7.Mapping of the nucleic acid binding sites in the Gn-CT of TULV. The Gn-CT (amino acids 525–638) peptides as 20-mers in a 3-residue shift were synthesized and printed on
glass slides in CelluSpot™ format. The IRdye800-conjugated 42-mer single-stranded DNA overlay assay and detection in Odyssey imaging system were performed as for PUUV (A).
The detected signal for each individual peptide is shown on the left side next to the amino acid sequence of the respective 20-mer peptide. TULV Gn-CT (wt) and its 13 amino acid C-
terminal deletion (del13) expressed as GST-fusion proteins were separated in 10% SDS- PAGE, blotted onto nitrocellulose and visualized by Ponceau S staining (B). M indicates a
marker lane. Nucleic acid binding of Gn-CT and Gn-CTdel13 of TULV were compared (C). GST-fused TULV Gn-CT and TULV Gn-CTdel13 were bound on glutathione beads and
analyzed for nucleic acid binding of RNA (
32
P-S-RNA in 400 CPM and
32
P-unRNA in 500 CPM) and DNA (IRdye800-conjugated 42mer 3′-end of hantavirus S-segment, 100 nM) as in
original comparison of GST-Gn-CTs of PUUV and TULV (Fig. 4). The fold of change to GST control is indicated.
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genome is recognized via packaging signals formed of secondary
structures in RNA (Hutchinson et al., 2010). Although the exact
mechanism of genome incorporation in to virions is not known, it has
been shown that the matrix protein M1 interacts with RNP (Baudin
et al., 2001; Elster et al., 1997; Noton et al., 2007; Ye et al., 1999). TheM1
protein harbors a ZF and a nuclear localization signal with RNA-binding
abilities (Elster et al., 1997; Wakeﬁeld and Brownlee, 1989; Ye et al.,
1999; Ye et al., 1989). Interestingly, the inﬂuenzaM1has been shown to
repress endogenous viral transcription through its RNA-binding
domains (Perez and Donis, 1998; Watanabe et al., 1996; Ye et al.,
1989). This activity could be biologically relevant in the late stages of
infection where it would halt viral mRNA production and thereby
trigger the packaging of viral genome eventually leading to the egress of
virions. Similarly to inﬂuenza M1, the matrix protein Z of arenaviruses
also acts as a transcriptional repressor (Cornu and de la Torre, 2001;
Cornu and de la Torre, 2002; Lopez et al., 2001), and a ZF domain is
required for this activity. Curiously, most bunyavirus Gn-CTs also
contain a ZF domain (Estrada et al., 2009) the functions of which are
currently unknown. Unlike the ZF domain of CCHFV, the ZF-domain of
hantavirus Gn-CT is unable to bind RNA directly (Estrada and De
Guzman, 2011). However, according to the results of the present study
there are other motifs in Gn-CT capable of binding RNA and thus a
regulatory role in viral transcription for the hantavirus ZF cannot be
ruled out. Since the matrix proteins of some non-segmented negative-
sense RNA viruses have also been described to regulate transcriptionthrough interaction with the RNP (Ghildyal et al., 2002; Iwasaki et al.,
2009; Suryanarayana et al., 1994), it is intriguing to speculate that
hantavirus Gn-CT would, through binding to RNP, mediate regulatory
functions in gene expression and in virion packaging. Further studies
regarding the functions of Gn-CT in hantavirus assembly or replication
would greatly beneﬁt from reverse genetics or infectious virus-like
particle generation systems that are unfortunately still lacking today for
these viruses.
Materials and methods
Hantavirus cultivation, radiolabeling and puriﬁcation
PUUV Sotkamo strain and TULV Moravia strain 5302 were propa-
gated in Vero E6 cells (green monkey kidney epithelial cell line; ATCC:
CRL-1586) in which they have been isolated and to which they are
adapted producing titers of 104 to 108 FFU/ml in to conditionedmedium
(Schmaljohn et al., 1985; Strandin et al., 2008; Vapalahti et al., 1996).
Vero E6 cells, grown at 37 °C in a humidiﬁed atmosphere containing 5%
CO2, were propagated inminimal essential medium supplemented with
10% heat-inactivated fetal calf serum, 2 mM glutamine, 100 IU/ml of
penicillin and 100 μg/ml of streptomycin. Cell cultures in 75-cm2 ﬂasks
were inoculated for 1 h at 37 °C with virus suspension and conditioned
mediumcollected7–10 dayspost infection (d.p.i.) for TULVand12–21 d.
p.i. for PUUV.Conditionedmediumcontainingvirus (stored in aliquots at
−70 °C) was used as an inoculum. For radiolabeling of viral proteins
18 T. Strandin et al. / Virology 418 (2011) 12–20infected Vero E6 cell cultures were starved for 1 h at 37 °Cwithmedium
depleted of methionine and cysteine, and propagated with a 1 mCi
mixture of
35
S-cysteine and
35
S-methionine (Wallac Perkin-Elmer) for
3 days at 37 °C. For puriﬁcation and concentration of viruses, cell culture
medium, passed through a 0.22-μm ﬁlter (Millipore), was concentrated
by pelleting through a 30% (w/v) sucrose cushion (Beckman SW28 rotor,
27,000 rpm, 2 h, 4 °C) and suspended in 25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) pH 7.4; 150 mM NaCl (HBS).Antibodies and reagents
Neutralizing bank vole monoclonal antibodies (MAbs) directed to
PUUV Gn (5A2) and Gc (4G2) and to PUUV N (5E1) and TULV N
(3C11) (Lundkvist and Niklasson, 1992; Lundkvist et al., 1993;
Lundkvist et al., 1996a; Lundkvist et al., 1996b) were kindly provided
by Prof. Åke Lundkvist (Swedish Institute for Infectious Disease
Control). Polyclonal antisera (PAbs) raised against glutathione-S-
transferase (GST) fusion proteins of PUUV Gn, Gc and N have been
described previously (Vapalahti et al., 1995). The anti-hemagglutinin
(HA) MAb was from Abcam. The IRdye800- and AlexaFluor680-
conjugated secondary antibodies were from Li-COR and Invitrogen,
respectively. Micrococcal nuclease (MNase) and RNase A were from
MBI Fermentas.Nucleic acids
The genomic PUUV S segment was in vitro transcribed (Tran-
scriptAid™ T7 High Yield Transcription Kit; MBI Fermentas) from a
pGEM-T plasmid containing the respective sequence information
under a T7 promoter. The PUUV S segment together with an unrelated
RNA (unRNA) of similar size (included in TranscriptAid™ T7 High
Yield Transcription Kit; MBI Fermentas) were radioactively labeled
with
32
P-UTP (Wallac PerkinElmer) during transcription and puriﬁed
using Tripure (Roche). The speciﬁc activity of these RNAs was
assumed similar since both contained approximately 1/3 of uridine
residues. Successful RNA synthesis was veriﬁed on a denaturing
polyacrylamide gel electrophoresis (PAGE) in 5% gel containing 8 M
urea in TBE buffer (22.5 mM Tris base, 22.5 mM boric acid, 2.5 mM
EDTA). The gel was dried and RNA visualized by autoradiography. The
42-mer single-stranded DNA represented the 3′-end of the genomic
PUUV S segment: 5′-TCCAGACTTTCTCGTAGTAGCTTTTCAAGGAGTC-
TACTACTA-3′. An IRdye800-moiety was conjugated to the 5′-end of
the oligonucleotide which was synthesized by Oligomer Oy, Finland.Cross-linking
The puriﬁed PUUV or TULV, lysed in 0.5% TritonX-100, were
treated with 0.1 U/μl MNase in 50 mM Tris–HCl pH 7.5; 5 mM CaCl2
for 1 h at 37 °C. MNase was inactivated with 10 mM ethylene glycol
tetra-acetic acid (EGTA) for 15 min at room temperature prior to
addition of
32
P-labeled RNA, that was added in amounts of 500 counts
perminute (CPM) of PUUV S segment to both PUUV and TULV extracts
or 2500 CPM of unrelated RNA (unRNA) to TULV. After 2-h incubation
at RT the RNAs were cross-linked to proteins under a UV lamp for
30 min at RT and RNA cleaved with 10 μg RNase A for 1 h at 37 °C. The
enzyme was inactivated by addition of Laemmli sample buffer,
samples boiled and proteins separated on 6% SDS-PAGE. To visualize
the RNA-interacting proteins, the gel was either subjected to
autoradiography or proteins were transferred to nitrocellulose and
immunoblotted with Gn- or Gc-speciﬁc PAbs and N-speciﬁc 3C11 or
5E1 MAbs. After probing with infrared dye-conjugated secondary
antibodies the results were visualized by Odyssey infrared detection
system (Li-COR).Immunoprecipitation
The PUUV or TULV preparations, incubated with radioactive RNA
prior to cross-linking as described earlier, were subjected to
immunoprecipitation in binding buffer (BB; 50 mM Tris–HCl,
150 mM NaCl, 0.1% Triton X-100). Firstly, 10 μg of MAbs (5A2, 4G2,
5E1 or HA) or 20 μl of PAbs (Gn-, Gc-, N-speciﬁc or negative serum)
were incubated with the samples for 1 h at RT. Then 10 μl of Protein G
Sepharose beads (GE Healthcare) were added and incubation
continued for 1 h under end-over-end rotation in Eppendorf tubes
at RT. The beads were then washed two times with BB and liquid
removed prior to scintillation counting (Cerenkov-
32
P; Wallac 140
MicroBeta Trilux liquid scintillation counter). The results were
calculated as a fold change in respect to a negative control sample.
The efﬁciency of Gn-, Gc- or negative PAb to bind viral proteins was
monitored with metabolically radiolabeled virion lysates of PUUV or
TULV by immunoprecipitation similarly as described earlier. The
protein G bound protein complexes were eluted to Laemmli sample
buffer, boiled and separated in 10% SDS-PAGE. The gel was dried and
proteins visualized by autoradiography.Recombinant protein production
The Gn-CTs of PUUV and TULV were expressed as glutathione S-
transferase (GST) fusion proteins in E. coli according to protocols of
the manufacturer (GST Gene Fusion System Handbook, Amersham
Bioscience 18-1157-58 Edition AA). The expression plasmids for GST-
tagged Gn-CTs were constructed by inserting respective Gn-CT
fragments (residues 526–637 of PUUV and 521–632 of TULV) into
the pGEX-4T-3 vector (GE Healthcare). Protein production was
induced by addition of 0.5 mM isopropyl β-D-1-thiogalactopyrano-
side (IPTG) to cultures at 0.5 OD600, protein expressionwas performed
under vigorous shaking over 4 h at 30 °C, bacteria were lysed and the
expressed GST and GST-fusion proteins were puriﬁed by glutathione
(GSH) Sepharose 4B beads (Amersham Pharmacia, GE Healthcare)
using HBS as washing buffer. The GST-fusion protein with GST as the
negative control (eluted from 10 μl of GSH beads to reducing Laemmli
sample buffer) was separated in 6% SDS-PAGE in Tris/tricine/SDS
running buffer (Bio-Rad) or in conventional 12% SDS-PAGE, and the
proteins were transferred to nitrocellulose for recording of the
relative protein amounts by Ponceau S staining.Pull-downs
The synthesis of biotin-conjugated peptides GnN, GnM, GnC and Gc-
CT has been described earlier (Hepojoki et al., 2010b) and contained the
following amino acid sequences: GnN = Biotin-KVKKEYQKTMGSMV-
CEVC-OH, GnM = Biotin-QAHFKVCKLTSRFQENLKK-OH, GnC = Biotin-
EPMQGCYRTLSLFRYRS-OH and Gc-CT = Biotin-CPRRPSYKKDHKP-OH.
These peptides or biotin as a negative control were bound on
monomeric avidin beads (Pierce) at saturating amounts. The GST-
fusion protein coated on GSH and biotinylated peptide coated on
avidin beads were used in the pull-down experiments of the
radiolabeled S segment RNA (400 CPM) or unRNA (500 CPM). After
1 h incubation under shaking in BB at RT the beads were washed twice
with BB and the amount of bound RNA detected by scintillation
counting. For the binding of DNA, the IRdye800-conjugated single-
strandedoligonucleotide (100 nM)was incubated for 1 hunder shaking
atRT and theboundDNAwaseluted after twowasheswithBBbyboiling
in Laemmli sample buffer. 1 μl of the LSB eluate (corresponding to 1 μl
bead volume) was dot-blotted on to nitrocellulose, cross-linked by UV
and the amount of IRdye800-conjugated oligonucleotide quantiﬁed
usingOdyssey. The results are presentedas a fold changeas compared to
negative control.
19T. Strandin et al. / Virology 418 (2011) 12–20CelluSpot™ peptide arrays
Gn-CTs of TULV and PUUV were synthesized in CelluSpot™ format
as 20-residue long peptides on MultiPep synthesizer (Intavis Ag) and
the slides printed with SlideSpotter (Intavis Ag), all according to the
manufacturer's instructions as described (Beutling et al., 2008). Prior
to probing, the peptide array slides were rinsed with ethanol and
incubated in 10 mM Tris–HCl pH 8.0, 100 mM NaCl, 1 mM ethylene-
diaminetetraacetic acid (EDTA) and 0.0005% Tween-20 (TENT) for
5 min. The 5′-IRdye800-conjugated oligonucleotide was applied in
blocking buffer for 1 h at RT, unbound DNA washed from slide with
TENT and bound DNA detected with Odyssey.
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